Christophe Corpechot

16PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersPacific Peoples theory of change models for healthToxicology (incl. clinical toxicology)Haematological tumoursEmergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 30, 2025
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 Patients.

Florian Veyre, Eleonora De Martin, Domitille Erard

|Jul 14, 2025
PBC-HOPE: A Randomized Controlled Trial of Hypnosis and Psychoeducation in Women With Primary Biliary Cholangitis and Fatigue.

Aurélie Untas, Cécile Goffette, Cécile Flahault

|Jun 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.

Cynthia Levy, Palak J Trivedi, Kris V Kowdley

|Jun 10, 2024
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement.

Aldo J Montano-Loza, Christophe Corpechot, Patrizia Burra

|Jan 19, 2024
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting.

Christophe Corpechot, Marie Verdoux, Marie Frank-Soltysiak

|Oct 11, 2023
Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndrome.

Pierre-Antoine Soret, Sara Lemoinne, Maxime Mallet

Pageof 3